
Sherlock Bioscience and Mologic enter partnership
Mologic said it will invest a part of an expansion to its $4.9m grant from the Bill and Melinda-Gates Foundation to finance access to Sherlock's...

New malaria lead kills 99.9% of pathogens
The researchers built on the fact, that Plasmodium is highly dependent on external supply and metabolisation of vitamin B 5 (pantothenamide). They...

Magenta Therapeutics exercises ATAC licence option
Stem cell specialist Magenta Therapeutics (Cambridge, MA, USA) agreed to pay up to $85m in milestones for the rights to exclusively develop and...

GeNeuro and Karolinska Institute collaborate in multiple sclerosis
The 12-months trial, which will kick-off in QI/2020, will be led by Dr. Fredrik Piehl, head of research at the MS clinic at ASC in Stockholm, which...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...

UniQure looking to raise US$200m
The Amsterdam-based company announced that it had commenced an underwritten public offering of US$200m of its ordinary shares. uniQure also intends...

AMR: ENABLE selects Mutabilis candidate
Efficacy of beta-lactam antibiotics, which represent 65% of the antibiotics sold throughout the world, is increasingly challenged in Gram-negative...